首页> 美国卫生研究院文献>Critical Care >Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture
【2h】

Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture

机译:Tezosentan降低盲肠结扎和穿刺大鼠离体肺微血管过滤系数

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionWe recently demonstrated that the non-selective endothelin-1 (ET-1) receptor blocker tezosentan antagonizes ovine acute lung injury (ALI) following infusion of endotoxin or ET-1 by reducing the enhanced lung microvascular pressure, although we could not exclude the possibility of a simultaneous decline in microvascular permeability. In the present study, our aim was to find out if tezosentan reverses the rise in microvascular filtration coefficient (Kfc) in rat lungs that have been isolated and perfused 12 h after cecum ligation and puncture (CLP) or infusion of ET-1.
机译:前言我们最近证明了非选择性内皮素-1(ET-1)受体阻滞剂替佐生坦可通过降低增强的肺微血管压力来拮抗输注内毒素或ET-1后的绵羊急性肺损伤(ALI),尽管我们不能排除这种可能性微血管通透性的同时下降。在本研究中,我们的目的是发现替佐生坦是否能逆转盲肠结扎穿刺(CLP)或输注ET-1后12 h分离并灌注的大鼠肺中微血管滤过系数(Kfc)的升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号